Campinas Poison Control Center, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
Department of Pediatrics, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
Clin Toxicol (Phila). 2021 Feb;59(2):158-168. doi: 10.1080/15563650.2020.1771358. Epub 2020 Jun 1.
To report a near-fatal poisoning after intentional injection of ricin from a castor bean () extract.
A 21 year-old man self-injected ∼3 mL of a castor bean extract intramuscularly and subcutaneously in the left antecubital fossa. Upon admission to our ED (1 h post-exposure; day 1, D1) he was awake and alert, but complained of mild local pain and showed slight local edema and erythema. He evolved to refractory shock (∼24 h post-exposure) that required the administration of a large volume of fluids and high doses of norepinephrine and vasopressin, mainly from D2 to D4. During this period, he developed clinical and laboratory features compatible with systemic inflammatory response syndrome, multiple organ dysfunction, capillary leak syndrome, rhabdomyolysis, necrotizing fasciitis and possible compartment syndrome. The patient underwent forearm fasciotomy on D4 and there was progressive improvement of the hemodynamic status from D7 onwards. Wound management involved several debridements, broad-spectrum antibiotics and two skin grafts. Major laboratory findings within 12 days post-exposure revealed hypoalbuminemia, proteinuria, thrombocytopenia, leukocytosis and increases in cytokines (IL-6, IL-10 and TNF-α), troponin and creatine kinase. Ricin A-chain (ELISA) was detected in serum up to D3 (peak at 24 h post-exposure), with ∼79% being excreted in the urine within 64 h post-exposure. Ricinine was detected in serum and urine by LC-MS up to D5. A ricin A-chain concentration of 246 µg/mL was found in the seed extract, corresponding to the injection of ∼738 µg of ricin A-chain (∼10.5 µg/kg). The patient was discharged on D71, with limited range of motion and function of the left forearm and hand.
Ricin injection resulted in a near-fatal poisoning that evolved with septic shock-like syndrome, multiple organ dysfunction and necrotizing fasciitis, all of which were successfully treated with supportive care.
报告一例因摄入蓖麻毒素()提取物而导致的近乎致命性中毒。
一名 21 岁男性自行将约 3 毫升的蓖麻提取物肌内和皮下注射到左侧肘前窝。在被送到我们的急诊部(暴露后 1 小时;第 1 天,D1)时,他意识清醒,但诉轻度局部疼痛,并显示轻微的局部肿胀和红斑。他进展为难治性休克(暴露后约 24 小时),需要大量液体和大剂量去甲肾上腺素和血管加压素治疗,主要从 D2 到 D4。在此期间,他出现了与全身炎症反应综合征、多器官功能障碍、毛细血管渗漏综合征、横纹肌溶解症、坏死性筋膜炎和可能的间隔综合征相符的临床和实验室特征。患者在 D4 进行了前臂筋膜切开术,从 D7 开始血流动力学状态逐渐改善。伤口管理包括多次清创术、广谱抗生素和两次植皮。暴露后 12 天内的主要实验室发现包括低白蛋白血症、蛋白尿、血小板减少症、白细胞增多和细胞因子(IL-6、IL-10 和 TNF-α)、肌钙蛋白和肌酸激酶增加。血清中检测到蓖麻毒素 A 链(ELISA)直至 D3(暴露后 24 小时达峰值),暴露后 64 小时内约 79%的毒素经尿液排泄。LC-MS 检测到血清和尿液中存在蓖麻碱,直至 D5。在种子提取物中发现蓖麻毒素 A 链浓度为 246μg/mL,相当于注射了约 738μg 的蓖麻毒素 A 链(约 10.5μg/kg)。患者在 D71 出院,左侧前臂和手部活动和功能受限。
蓖麻毒素注射导致近乎致命性中毒,进展为类似败血症性休克的综合征、多器官功能障碍和坏死性筋膜炎,所有这些都通过支持性治疗成功治疗。